PMID: 6111532Mar 1, 1981Paper

Short-term systemic hemodynamic adaptation to beta-adrenergic inhibition with atenolol in hypertensive patients

Hypertension
G SimonJ N Cohn

Abstract

Early systemic hemodynamic adjustments to antihypertensive therapy with the cardioselective beta inhibitor, atenolol, were investigated in 12 hospitalized men, mean age 52 years, with uncomplicated mild-to-moderate essential hypertension. Twice daily measurements of cardiac output (CO) by CO2 rebreathing, blood pressure by cuff, and heart rate were performed in all subjects for 3 days before and 5 days after initiation of oral atenolol therapy (50 or 100 mg daily). Cardiac output by CO2 rebreathing was checked with dye dilution just before, and 4 hours and 4 days after the start of therapy. Plasma volume (radioiodinated albumin) was measured before therapy and on Day 5 of therapy. The CO results obtained with the two methods were not significantly different (r = 0.88, p less than 0.01, n = 12). A reduction in heart rate, 18 +/- 2 beats/min (mean +/- SE), occurred in all patients while taking atenolol. By 4 hours after the first dose of atenolol, CO fell from 5.49 +/- 0./30 to 4.24 +/- 0.21 liters/min (p less than 0.01), while the control mean arterial pressure (MAP) of 108 +/- 4 mm Hg was not significantly changed, 110 +/- 4 mm Hg. At 24 hours, CO returned near baseline (5.10 +/- 0.21 liters/min) but MAP was reduced (95 +/- 3 m...Continue Reading

References

Jun 1, 1977·The American Journal of Physiology·M A PfefferE D Frohlich
Apr 1, 1976·Circulation Research·D B AverillR Bajbus
Mar 1, 1977·American Heart Journal·J C PetrieJ Webster
Feb 1, 1977·British Journal of Clinical Pharmacology·R Sannerstedt, H Wasir
Jul 1, 1973·British Heart Journal·B S LewisM S Gotsman
Sep 1, 1972·Proceedings of the Society for Experimental Biology and Medicine·E D FrohlichE D Jacobson
Dec 1, 1971·American Heart Journal·R C TaraziH P Dustan
Jul 1, 1972·Proceedings of the Society for Experimental Biology and Medicine·S JuliusR London
May 1, 1973·British Heart Journal·P A MajidS H Taylor
May 1, 1971·Circulation Research·T G ColemanA C Guyton
Nov 1, 1968·The American Journal of Cardiology·J A NicoteroA P Shapiro
Sep 1, 1966·The American Journal of Cardiology·I BrickI C Roddie
Oct 1, 1966·British Journal of Pharmacology and Chemotherapy·S O Kayaalp, B K Kiran
Dec 1, 1961·The American Journal of Cardiology·J CONWAY, P LAUWERS

❮ Previous
Next ❯

Citations

May 21, 1983·Lancet·R C Bryant
Jan 1, 1985·Clinical and Experimental Hypertension. Part A, Theory and Practice·M A van BaakJ F Smits
Jun 15, 1988·The American Journal of Cardiology·M R Weir, E Saunders
Jan 1, 1987·British Journal of Clinical Pharmacology·A H van den MeirackerM A Schalekamp
Apr 26, 1985·The American Journal of Cardiology·J N Cohn
Feb 17, 2001·Biopharmaceutics & Drug Disposition·S MostafaviR Foster
Mar 1, 1984·Hypertension·P I Korner
Jan 1, 1985·Acta Medica Scandinavica. Supplementum·P Lund-JohansenH Haugland

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.